Solstein Capital’s Blend Labs BLND Stock Holding History

Solstein Capital’s Portfolio BLND Stock Details BLND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,952	Closed	-$14K	–	312
2022 Q2	$14K	Sell	5,952 -5,952	-50%	-$22.3K	0.01%	239
2022 Q1	$68K	Buy	+11,904	New	+$92.2K	0.04%	172

Other funds holding BLND

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LUGPI

Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Greylock 15 Menlo Park, California $85.6M AUM 199.44% 1-Year Est. Return

ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

EGP

Emergence GP Partners San Francisco, California $111M AUM 28.73% 1-Year Est. Return

Solstein Capital's BLND Position: Q3 2022 in Review

Solstein Capital sold out of Blend Labs (BLND) in Q3 2022, closing a stake of 5,952 shares — an estimated $14K sold.

Solstein Capital first reported a position in BLND in Q1 2022 and held it in 2 quarters. The position peaked at $68K in Q1 2022. 119 funds tracked by Wall St. Rank hold BLND as of Q3 2022.

Solstein Capital reported no remaining Blend Labs position as of Q3 2022 after selling out during the quarter.
Solstein Capital sold 5,952 Blend Labs shares in Q3 2022, an estimated $14K.
Solstein Capital first reported a position in Blend Labs in Q1 2022 and held it in 2 quarters.
Solstein Capital's Blend Labs position peaked at $68K in Q1 2022.
119 funds tracked by Wall St. Rank held Blend Labs as of Q3 2022.

Based on Solstein Capital's 13F filing for Q3 2022, filed 1 Nov 2022.